Board Moves.

Acelyrin (NASDAQ: SLRN)

Mina Kim promoted to Chief Executive Officer and she is appointed to the Board of Directors. Ms. Kim is the former Chief Legal Officer & Head of Corporate Development at Zymergen.

Anika Therapeutics (NASDAQ: ANIK)

Appoints Joseph Capper and William Jellison to the Board of Directors. Mr. Capper is the Chief Executive Officer at MIMEDX and Mr. Jellison is the former Chief Financial Officer at Stryker.

Apogee Therapeutics (NASDAQ: APGE)

Appoints Lisa Bollinger to the Board of Directors. Ms. Bollinger is the former VP Global Regulatory Affairs & Clinical Safety, US FDA at Merck.

Arrivent Biopharma (NASDAQ: AVBP)

Appoints John Hohneker to the Board of Directors. Mr. Hohneker is the former Chief Executive Officer at Anokion SA.

ATAI Life Sciences NV (NASDAQ: ATAI)

Srinivas Rao promoted to CEO-elect and he is appointed to the Board of Directors. Mr. Rao is the Co-Founder and Chief Scientific Officer at ATAI Life Sciences NV.

Avadel Pharmaceuticals (NASDAQ: AVDL)

Appoints Naseem Amin to the Board of Directors. Mr. Amin is the Chief Executive Officer at Orphalan SA.

Bio-Techne (NASDAQ: TECH)

Appoints Judith Klimovsky to the Board of Directors. Ms. Klimovsky is the Chief Development Officer at Genmab.

Boston Scientific (NYSE: BSX)

Appoints Cheryl Pegus to the Board of Directors. Ms. Pegus is the former EVP Health & Wellness at Walmart.

Contineum Therapeutics (NASDAQ: CTNM)

Appoints Troy Ignelzi to the Board of Directors. Mr. Ignelzi is the former Chief Financial Officer at Rapport Therapeutics.

Cullinan Therapeutics (NASDAQ: CGEM)

Appoints David Meek to the Board of Directors. Mr. Meek is the former Chief Executive Officer at Mirati Therapeutics.

Edgewise Therapeutics (NASDAQ: EWTX)

Appoints Arlene Morris to the Board of Directors. Ms. Morris is the former Chief Executive Officer at Willow Advisors.

Fortrea (NASDAQ: FTRE)

Appoints Machelle Sanders to the Board of Directors. Ms. Sanders is the former Vice President, Multiple Sclerosis Franchise Product Operations at Biogen.

Immunocore (NASDAQ: IMCR)

Appoints Ranjeev Krishana to the Board of Directors. Mr. Krishna is a Partner at Baker Bros.

Innoviva (NASDAQ: INVA)

Appoints Derek Small to the Board of Directors. Mr. Small is a Managing Director at Luson Bioventures.

Keros Therapeutics (NASDAQ: KROS)

Appoints Jean-Jacques Bienaime to the Board of Directors. Mr. Bienaime is the former Chief Executive Officer at BioMarin Pharmaceutical.

Lifecore Biomedical (NASDAQ: LFCR)

Names Paul Josephs Chief Executive Officer and he is appointed to the Board of Directors.

LifeMD (NASDAQ: LFMD)

Appoints Calum MacRae to the Board of Directors. Mr. MacRae is a Professor of Medicine at Harvard Medical School.

Neurocrine Biosciences (NASDAQ: NBIX)

Promotes Kyle Gano to Chief Executive Officer and he is appointed to the Board of Directors.

Prestige Consumer Healthcare (NYSE: PBH)

Appoints John Kelly to the Board of Directors. Mr. Kelly is the former VP Quality Ops & EH&S at Pfizer.

Pulse Biosciences (NASDAQ: PLSE)

Burke Barrett named CEO and he is appointed to the Board of Directors. Mr. Barrett is the former Chief Executive Officer at CaridoFocus.

Quest Diagnostics (NYSE: DGX)

Appoints Robert Carter to the Board of Directors. Mr. Carter is the Chief Information Officer at FedEx & Co-President & Co-CEO at FedEx Services.

QuidelOrtho (NASDAQ: QDEL)

Brian Blaser named CEO and he is appointed to the Board of Directors. Mr. Blaser is the former EVP, Diagnostic Products at Abbott.

Sonida Senior Living (NYSE: SNDA)

Appoints Lilly Donohue to the Board of Directors. Ms. Donohue is the Chief Executive Officer at Everstory Partners.

Spyre Therapeutics (NASDAQ: SYRE)

Appoints Sandra Milligan to the Board of Directors. Ms. Milligan is the President at Aspira Women’s Health.

Syndax Pharmaceuticals (NASDAQ: SNDX)

Appoints Aleksandra Rizo to the Board of Directors. Ms. Rizo is the Chief Executive Officer at Vividion.

‍

‍

180 Life Sciences (NASDAQ: ATNF)

James Woody resigns as CEO and from the Board of Directors. Mr. Woody is the General Partner at Latterell Venture Partners.

ALX Oncology (NASDAQ: ALXO)

Jack Nielsen and Itziar Canamasas resign from the Board of Directors. Mr. Nielsen is a Managing Director at Vivo Capital and Mr. Canamasas is the Chief Executive Officer at AtG Therapeutics.

ATAI Life Sciences NV (NASDAQ: ATAI)

Jason Camm resigns from the Board of Directors. Mr. Camm is the Managing Director and Chief Medical Officer at Thiel Capital.

Azenta (NASDAQ: AZTA)

Stephen Schwartz retires as CEO and from the Board of Directors. Mr. Schwartz is the former President, Chief Executive Officer & Chairman at Asyst Technologies, Inc.

Collegium Pharmaceutical (NASDAQ: COLL)

Joseph Ciaffoni departs as CEO and from the Board of Directors. Mr. Ciaffoni is the former President, US Branded Pharmaceuticals at Endo Pharmaceuticals.

Cytokinetics (NASDAQ: CYTK)

Sandford Smith resigns from the Board of Directors. Mr. Smith is the Founder and Chairman of the Board at Global Biolink Partners.

Lexicon Pharmaceuticals (NASDAQ: LXRX)

Lonnel Coats retires as CEO and from the Board of Directors. Mr. Coats is the former Chief Executive Officer of Eisai, Inc.

Longboard Pharmaceuticals (NASDAQ: LBPH)

Jane Tiller resigns from the Board of Directors. Ms. Tiller is the Chief Medical Officer at Neumora Therapeutics.

Y-mAbs Therapeutics (NASDAQ: YMAB)

Gerard Ber resigns from the Board of Directors. Mr. Ber is a former Co-Founder and Chief Operating Officer at Advanced Accelerator Applications S.A.

Zoetis (NYSE: ZTS)

Linda Rhodes retires from the Board of Directors. Ms. Rhodes is the former Chief Scientific Officer and CEO at Aratana Therapeutics.